During the third quarter of 2014 start-up companies raised a total of $1.19 billion, a 33% increase from the previous quarter’s $893.9 million and the new record for start-up fundraising in a single quarter since this column debuted five years ago. (Q1 2014’s $1.18 billion had been the highest.) Biopharma companies pulled in 89% ($1.05 billion), with public financings (IPOs and follow-ons) accounting for half of that money. Six medical device start-ups closed Series A rounds, representing 80% of the $57.2 million raised in that industry. Five in vitro diagnostics companies took in a combined $77.6 million. (See Exhibit 1.)
Exhibit 1
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
